Overview

Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A prospective observational multi centre research study in GP practices clustered within up to 10 UK Primary care trusts.
Details
Lead Sponsor:
Novartis Pharmaceuticals